Antibiotic Resistance Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

MARKET INTRODUCTION

Antimicrobial substances that is used to combat bacterial infection are termed as antibiotics. These are used to heal several medical conditions like stroke, sinus, urinary tract infections, ear infections, pneumonia, skin infections, and other diseases. The classification of antibiotics is based on chemical structures, activity spectrum, and action method. The capacity to withstand the infection is known as resistance to antibiotics. Worldwide, this is expected to be a key issue, leading to the full-fledged emergence of the global antibiotic resistance market.

MARKET DYNAMICS

The artificial intelligence in the healthcare diagnosis market is driven by many pharmaceutical companies are focusing to develop the antibiotic resistance drugs. However, lack of interest of investor for the research and development of antibiotics resistance therapies will also hamper the development of antibiotic resistance market. Moreover, rising number of patient pool suffering from bacterial infection is the primary factor driving the growth of antibiotic resistance market over the forecast period

MARKET SCOPE

The "Antibiotic Resistance Market Analysis to 2031" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of antibiotic resistance market with detailed market segmentation by drug class and distribution channel. The antibiotic resistance market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in antibiotic resistance market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The antibiotic resistance market is segmented on the basis of drug class and distribution channel. Based on drug class, the market is segmented as oxazolidinones, cephalosporins, tetracyclines, lipoglycopeptides and others. On the basis of distribution channel, the market is categorized as hospital pharmacies, retail pharmacies, drug stores and online pharmacies.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the antibiotic resistance market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The antibiotic resistance market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting antibiotic resistance market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the antibiotic resistance market in these regions.

MARKET PLAYERS

The report covers key developments in the antibiotic resistance market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from antibiotic resistance market are anticipated to have lucrative growth opportunities in the future with the rising demand for antibiotic resistance in the global market. Below mentioned is the list of few companies engaged in the antibiotic resistance market.

The report also includes the profiles of key players in antibiotic resistance market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

•   Achaogen, Inc.
  
•   Basilea Pharmaceutica Ltd.
  
•   Entasis Therapeutics
  
•   Melinta Therapeutics
  
•   PARATEK therapeutics
  
•   Seres Therapeutics, Inc.
  
•   Tetraphase Pharmaceuticals, Inc.
  
•   Theravance Biopharma, Inc
  
•   Wockhardt therapeutics
  
  

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.

Antibiotic Resistance Report Scope